ATAI Life Sciences NV at Citi BioPharma Conference (Virtual) Transcript
All right. So good afternoon, everybody, and thanks for attending Citi's 16th Annual Biopharma Conference. I'm Neena Bitritto-Garg, one of the biotech analysts here at Citi.
For our next session, I'm really happy to be joined by the CEOs of 2 companies addressing mental health conditions through studying psychedelic drugs, including George Goldsmith from COMPASS Pathways and Florian Brand from Atai Life Sciences. So over the next 45 minutes or so, we're going to talk about the potential for psychedelic medicines and mental health conditions as well as some specifics of each company's programs.
But before we do get into the discussion, if anybody listening has questions that you want me to ask, feel free to either e-mail me directly or submit your questions through the web portal, and then I can incorporate them if there is time.
So now I want to just turn it over to Florian and George to each give kind of a quick introduction. I don't know if we want to go alphabetically for anyone
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
